Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03090646 · ClinicalTrials.gov registry record · NA

Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance

A NA study of Nephrectomy and Living Donors, sponsored by Johns Hopkins University.

Active
Registry status
NA
Development phase
320
Enrollment target
2
Study locations

NCT03090646 is a NA study of Nephrectomy and Living Donors that is active but no longer recruiting, run by Johns Hopkins University. The registered enrollment target is 320 participants. The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03090646, a NA study of Nephrectomy and Living Donors, is active but no longer recruiting, sponsored by Johns Hopkins University.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
320 participants
Enrollment target
2
Study locations

Study Summary

This study evaluates whether using small financial incentives increases patient compliance with nationally-mandated living kidney donor follow-up at 6-months, 1-year, and 2-years after donation. Half of participants will receive a financial incentive (mailed gift card) after completing required follow-up activities (brief questionnaire and lab draw), while the other half will be asked to complete the required follow-up activities but will not receive a financial incentive (current standard of care).

Interventions

  • OTHER Financial Incentive

Study Locations (2)

Maryland

  • University of Maryland Medical Center Transplant Center - Baltimore
  • The Johns Hopkins Hospital Comprehensive Transplant Center - Baltimore

Trial Details

FieldValue
Enrollment Target 320 participants
Start Date 2017-03-22
Est. Completion 2026-08-01
Phase NA

Sponsor

Johns Hopkins University

1,448 total trials

What the Registry Record Tells You About NCT03090646

The ClinicalTrials.gov registry entry for NCT03090646 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 320 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Johns Hopkins University, which has 1,448 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Nephrectomy appearing as the primary indexed condition, and to 1 intervention - of which Financial Incentive is the first listed.

NCT03090646 reports 2 study locations spanning 1 distinct geographic area - top geographies include Maryland.

Frequently Asked Questions

What is clinical trial NCT03090646 about?

NCT03090646 is a clinical study titled "Use of Financial Incentives to Increase Live Kidney Donor Follow-up Compliance". This study evaluates whether using small financial incentives increases patient compliance with nationally-mandated living kidney donor follow-up at 6-months, 1-year, and 2-years after donation. Half of participants will receive a financial incentive (mailed gift card) after completing required foll...

What is the current status of trial NCT03090646?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 320 participants. The study started on 2017-03-22. Estimated completion is 2026-08-01.

What conditions does trial NCT03090646 study?

This clinical trial studies the following conditions: Nephrectomy, Living Donors, Kidney.

What interventions are being tested in trial NCT03090646?

The interventions under investigation include: Financial Incentive (OTHER).

Who is sponsoring clinical trial NCT03090646?

This trial is sponsored by Johns Hopkins University, which has 1,448 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03090646 being conducted?

This trial has 2 study locations across Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Nephrectomy

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.